Book contents
- Transient Ischemic Attack and Stroke
- Transient Ischemic Attack and Stroke
- Copyright page
- Contents
- Preface to the Second Edition
- Section 1 Epidemiology, Risk Factors, Pathophysiology, and Causes of Transient Ischemic Attacks and Stroke
- Chapter 1 Epidemiology
- Chapter 2 Risk Factors
- Chapter 3 Genetics
- Chapter 4 Anatomy and Physiology
- Chapter 5 Pathophysiology of Acute Cerebral Ischemia
- Chapter 6 Causes of Transient Ischemic Attack and Ischemic Stroke
- Chapter 7 Causes of Spontaneous Intracranial Hemorrhage
- Section 2 Clinical Features, Diagnosis, and Investigation
- Section 3 Prognosis of Transient Ischemic Attack and Stroke
- Section 4 Treatment of Transient Ischemic Attack and Stroke
- Section 5 Secondary Prevention
- Section 6 Miscellaneous Disorders
- Index
- References
Chapter 3 - Genetics
from Section 1 - Epidemiology, Risk Factors, Pathophysiology, and Causes of Transient Ischemic Attacks and Stroke
Published online by Cambridge University Press: 01 August 2018
Book contents
- Transient Ischemic Attack and Stroke
- Transient Ischemic Attack and Stroke
- Copyright page
- Contents
- Preface to the Second Edition
- Section 1 Epidemiology, Risk Factors, Pathophysiology, and Causes of Transient Ischemic Attacks and Stroke
- Chapter 1 Epidemiology
- Chapter 2 Risk Factors
- Chapter 3 Genetics
- Chapter 4 Anatomy and Physiology
- Chapter 5 Pathophysiology of Acute Cerebral Ischemia
- Chapter 6 Causes of Transient Ischemic Attack and Ischemic Stroke
- Chapter 7 Causes of Spontaneous Intracranial Hemorrhage
- Section 2 Clinical Features, Diagnosis, and Investigation
- Section 3 Prognosis of Transient Ischemic Attack and Stroke
- Section 4 Treatment of Transient Ischemic Attack and Stroke
- Section 5 Secondary Prevention
- Section 6 Miscellaneous Disorders
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Transient Ischemic Attack and StrokeDiagnosis, Investigation and Treatment, pp. 35 - 51Publisher: Cambridge University PressPrint publication year: 2018
References
Attems, J, Jellinger, K, Thal, DR et al. (2011). Review: Sporadic cerebral amyloid angiopathy. Neuropathology and Applied Neurobiology 37:75–93Google Scholar
Bellenguez, C, Bevan, S, Gschwendtner, A et al. (2012). Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nature Genetics 44:328–333Google Scholar
Bevan, S, Traylor, M, Adib-Samii, P et al. (2012). Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke 43:3161–3167CrossRefGoogle ScholarPubMed
Biffi, A, Sonni, A, Anderson, CD et al. (2010). Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Annals of Neurology 68:934–943CrossRefGoogle ScholarPubMed
Boehme, AK, Esenwa, C, Elkind, MSV (2017). Stroke risk factors, genetics and prevention. Circulation Research 120:472–495CrossRefGoogle ScholarPubMed
Brugada, R, Tapscott, T, Czernuszewicz, GZ et al. (1997). Identification of a genetic locus for familial atrial fibrillation. New England Journal of Medicine 336:905–911CrossRefGoogle ScholarPubMed
Carney, JA (1985). Differences between nonfamilial and familial cardiac myxoma. American Journal of Surgery and Pathology 9:53–55CrossRefGoogle ScholarPubMed
Casas, JP, Hingorani, AD, Bautista, LE et al. (2004). Meta-analysis of genetic studies in ischemic stroke: Thirty-two genes involving approximately 18 000 cases and 58 000 controls. Archives of Neurology 61:1652–1661CrossRefGoogle ScholarPubMed
Casas, JP, Cavalleri, GL, Bautista, LE et al. (2006). Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: A HuGE review. American Journal of Epidemiology 164:921–935CrossRefGoogle ScholarPubMed
Case, NF, Charlton, A, Zwiers, A et al. (2016). Cerebral amyloid angiopathy is associated with executive dysfunction and mild cognitive impairment. Stroke 47:2010–2016CrossRefGoogle ScholarPubMed
Chabriat, H, Vahedi, K, Iba-Zizen, MT et al. (1995). Clinical spectrum of CADASIL: A study of 7 families. Lancet 346:934–939Google Scholar
Chabriat, H, Levy, C, Taillia, H et al. (1998). Patterns of MRI lesions in CADASIL. Neurology 51:452–457Google Scholar
Charidimou, A, Gang, Q, Werring, DJ (2012). Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. Journal of Neurology, Neurosurgery and Psychiatry 83:124–137CrossRefGoogle ScholarPubMed
Charidimou, A, Baron, JC, Werring, DJ (2013). Transient focal neurological episodes, cerebral amyloid angiopathy, and intracerebral hemorrhage risk: Looking beyond TIAs. International Journal of Stroke 8:105–108Google Scholar
Devan, WJ, Falcone, GJ, Anderson, CD et al. (2013). Heritability estimates identify a substantial contribution to risk and outcome of intracerebral hemorrhage. Stroke 44:1578–1583Google Scholar
Dichgans, M, Markus, HS (2005). Genetic association studies in stroke: Methodological issues and proposed standard criteria. Stroke 36:2027–2031Google Scholar
Dichgans, M, Mayer, M, Müller-Myhsok, B et al. (1996). Identification of a key recombinant narrows the CADASIL gene region to 8 cM and argues against allelism of CADASIL and familial hemiplegic migraine. Genomics 32:151–154Google Scholar
Dichgans, M, Mayer, M, Uttner, I et al. (1998). The phenotypic spectrum of CADASIL: Clinical findings in 102 cases. Annals of Neurology 44:731–739Google Scholar
Dubroca, C, Lacombe, P, Domenga, V et al. (2005). Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy. Stroke 36:113–117CrossRefGoogle Scholar
Ebke, M, Dichgans, M, Bergmann, M et al. (1997). CADASIL: Skin biopsy allows diagnosis in early stages. Acta Neurology Scandinavica 95:351–357Google Scholar
Falcone, GJ, Malik, R, Dichgans, M et al. (2014). Current concepts and clinical applications of stroke genetics. Lancet Neurology 13:405–418Google Scholar
Flossmann, E, Schulz, UG, Rothwell, PM (2004). Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 35:212–227Google Scholar
Flossmann, E, Schulz, UG, Rothwell, PM (2005). Potential confounding by intermediate phenotypes in studies of the genetics of ischaemic stroke. Cerebrovascular Diseases 19:1–10Google Scholar
Fotiadis, P, van Rooden, S, van der Grond, J et al. (2016). Cortical atrophy in patients with cerebral amyloid angiopathy: A case-control study. Lancet Neurology 15:811–819Google Scholar
Franz, WM, Muller, OJ, Katus, HA (2001). Cardiomyopathies: From genetics to the prospect of treatment. Lancet 358:1627–1637CrossRefGoogle Scholar
French, CR, Seshadri, S, Destefano, AL et al. (2014). Mutation of FOXC1 and PITX2 induces cerebral small-vessel disease. Journal of Clinical Investigation 124:4877–4881CrossRefGoogle ScholarPubMed
Gould, DB, Phalan, FC, van Mil, SE et al. (2006). Role of COL4A1 in small-vessel disease and hemorrhagic stroke. New England Journal of Medicine 354:1489–1496CrossRefGoogle ScholarPubMed
Gretarsdottir, S, Thorleifsson, G, Manolescu, A et al. (2008). Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Annals of Neurology 64:402–409Google Scholar
Gudbjartsson, DF, Arnar, DO, Helgadottir, A et al. (2007). Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 448:353–357Google Scholar
Gudbjartsson, DF, Holm, H, Gretarsdottir, S et al. (2009). A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nature Genetics 41:876–878Google Scholar
Gulcher, JR, Gretarsdottir, S, Helgadottir, A et al. (2005). Genes contributing to risk for common forms of stroke. Trends in Molecular Medicine 11:217–224CrossRefGoogle ScholarPubMed
Gulcher, JR, Kong, A, Gretarsdottir, S et al. (2006). Reply to “Many hypotheses but no replication for the association between PDE4D and stroke.” Nature Genetics 38:1092–1093Google Scholar
Guo, JM, Liu, AJ, Zang, P et al. (2013). ALDH2 protects against stroke by clearing 4-HNE. Cell Research 23:915–930CrossRefGoogle ScholarPubMed
Hara, K, Shiga, A, Fukutake, T (2009). Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. New England Journal of Medicine 360:1729–1739Google Scholar
Hassan, A, Markus, HS (2000). Genetics and ischaemic stroke. Brain 123:1784–1812CrossRefGoogle ScholarPubMed
Hassan, A, Sham, PC, Markus, HS (2002). Planning genetic studies in human stroke: sample size estimates based on family history data. Neurology 58:1483–1488Google Scholar
Holliday, EG, Maguire, JM, Evans, TJ et al. (2012). Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nature Genetics 44:1147–1151Google Scholar
Humphries, SE, Morgan, L (2004). Genetic risk factors for stroke and carotid atherosclerosis: Insights into pathophysiology from candidate gene approaches. Lancet Neurology 3:227–235Google Scholar
Hutchinson, M, O’Riordan, J, Javed, M et al. (1995). Familial hemiplegic migraine and autosomal dominant ateriopathy with leukoencephalopathy (CADASIL). Annals of Neurology 38:817–824Google Scholar
Hutter, CM, Austin, MA, Humphries, SE (2004). Familial hypercholesterolemia, peripheral arterial disease and stroke: A HuGE minireview. American Journal of Epidemiology 160:430–435Google Scholar
Jeanne, M, Labelle-Dumais, C, Jorgensen, J et al. (2012). COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. American Journal of Human Genetics 90:91–101Google Scholar
Joutel, A, Corpechot, C, Ducros, A et al. (1996). Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707–710Google Scholar
Joutel, A, Vahedi, K, Corpechot, C et al. (1997). Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 350:1511–1515Google Scholar
Joutel, A, Dodick, DD, Parisi, JE et al. (2000). De novo mutation in the Notch3 gene causing CADASIL. Annals of Neurology 47:388–3913.0.CO;2-Q>CrossRefGoogle ScholarPubMed
Jung, HH, Bassetti, C, Tournier-Lasserve, E et al. (1995). Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: A clinicopathological and genetic study of a Swiss family. Journal of Neurology, Neurosurgery and Psychiatry 59:138–143CrossRefGoogle ScholarPubMed
Keavney, B, McKenzie, C, Parish, S et al. (2000). Large-scale test of hypothesised associations between the angiotensin-converting-enzyme, insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 355:434–442CrossRefGoogle ScholarPubMed
Lemmens, R, Buysschaert, I, Geelen, V et al. (2010). The association of the 4q25 susceptibility variant for atrial fibrillation with stroke is limited to stroke of cardioembolic etiology. Stroke 41:1850–1857Google Scholar
Lubitz, SA, Sinner, MF, Lunetta, KL et al. (2010). Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation 122:976–984CrossRefGoogle ScholarPubMed
Meschia, JF (2003). Familial hypercholesterolemia: Stroke and the broader perspective. Stroke 34:22–25Google Scholar
Meschia, JF, Arnett, DK, Ay, H et al. (2013). Stroke Genetics Network (SiGN) study: Design and rationale for a genome-wide association study of ischemic stroke subtypes. Stroke 44:2694–2702CrossRefGoogle ScholarPubMed
Monet-Lepretre, M, Bardot, B, Lemaire, B et al. (2009). Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain. Brain 132:1601–1612CrossRefGoogle ScholarPubMed
Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium; Stroke Genetics Network (SiGN); International Stroke Genetics Consortium (ISGC) (2016). Identification of additional risk loci for stroke and small vessel disease: A meta-analysis of genome-wide association studies. Lancet Neurology 15:695–707Google Scholar
NINDS Stroke Genetics Network (SiGN) and International Stroke Genetics Consortium (ISGC) (2016). Loci associated with ischemic stroke and its subtypes (SiGN): A genome-wide association study. Lancet Neurology 15:174–184Google Scholar
Razvi, SS M, Davidson, R, Bone, I et al. (2005). The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. Journal of Neurology, Neurosurgery and Psychiatry 76:739–741Google Scholar
Rolfs, A, Bottcher, T, Zschiesche, M et al. (2005). Prevalence of Fabry disease in patients with cryptogenic stroke: A prospective study. Lancet 366:1794–1796CrossRefGoogle ScholarPubMed
Rosand, J, Bayley, N, Rost, N et al. (2006). Many hypotheses but no replication for the association between PDE4D and stroke. Nature Genetics 38:1091–1092Google Scholar
Schulz, UG, Flossman, E, Rothwell, PM (2004). Heritability of ischemic stroke in relation to age, vascular risk factors and subtypes of incident stroke in population-based studies. Stroke 35:819–824Google Scholar
Singhal, S, Bevan, S, Barrick, T et al. (2004). The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 127:2031–2038Google Scholar
Sudlow, C, Martinez Gonzalez, NA, Kim, J et al. (2006). Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17 965 controls. Stroke 37:364–370CrossRefGoogle ScholarPubMed
Tournier-Lasserve, E, Joutel, A, Melki, J et al. (1993). Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nature Genetics 3:256–259CrossRefGoogle ScholarPubMed
Traylor, M, Farrall, M, Holliday, EG et al. (2012). Genetic risk factors for ischemic stroke and its subtypes (the METASTROKE Collaboration): A meta-analysis of genome-wide association studies. Lancet Neurology 11:951–962Google Scholar
Vahedi, K, Boukobza, M, Massin, P et al. (2007). Clinical and brain MRI follow-up study of a family with COL4A1 mutation. Neurology 69:1564–1568Google Scholar
van der Knaap, MS, Smit, LME, Barkhof, F et al. (2006). Neonatal porencephaly and adult stroke related to mutations in collage IV A1. Annals of Neurology 59:504–511Google Scholar
Weng, WC, Sonni, A, Labelle-Dumais, C et al. (2012). COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Annals of Neurology 71:470–477Google Scholar
Wheeler, JG, Keavney, BD, Watkins, H et al. (2004). Four paraoxonase gene polymorphisms in 11 212 cases of coronary heart disease and 12 786 controls: Meta-analysis of 43 studies. Lancet 363:689–695Google Scholar
Williams, FM, Carter, AM, Hysi, PG et al. (2013). Ischemic stroke is associated with the ABO locus: the EuroCLOT study. Annals of Neurology 73:16–31Google Scholar
Woo, D, Falcone, GJ, Devan, WJ et al. (2014). Meta-analyses of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage. American Journal of Human Genetics 94:511–521Google Scholar
Yamada, M (2015). Cerebral amyloid angiopathy: emerging concepts. Journal of Stroke 17:17–30Google Scholar
Yanagawa, S, Ito, N, Arima, K et al. (2002). Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Neurology 58:817–820Google Scholar